Kusajili – Clinical trials directory

Result of your search per sponsor: Joachim Drevs, PD Dr. Med

Woman and Man Max 99 years
Joachim Drevs, PD Dr. Med Update Il y a 4 ans

Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo The purpose of the study is to evaluate the efficacy and the safety of AMT2003 in cancer patients with advanced disease. The primary evaluation criterion is clinical benefit response.

Country Bosnia and Herzegovina, Germany
organs None
Specialty None

Closed trial

More information